chartexchange

CTNM
Contineum Therapeutics, Inc. Class A Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:30:25 PM EST
8.92USD-3.463%(-0.32)123,244
7.7500Bid8.9600Ask1.2100Spread

CTNM Financials

In Q3 FY 2026 (ended ), Contineum Therapeutics, Inc. Class A Common Stock (CTNM) reported net income of −$18.7M, operating cash flow of −$11.06M, and assets of $256.99M (filed ).

Loading financial statements…